Heart failure and chronic obstructive pulmonary disease
Adverse remodeling of the pulmonary vascular bed, and chronic systemic inflammation are common to both states.
Comorbidity of chronic obstructive pulmonary disease and heart failure poses serious problems of diagnostic and therapeutic nature and is associated with increased morbidity and mortality.
Cornerstones drugs therapy therapy CH beta-blockers and beta-agonists COPD are diametrically different pharmacological properties.
Heart failure and COPD exacerbation involved in each other and significantly increase the frequency of hospitalization and related health care costs.
Only early detection and treatment of heart failure and COPD can ease the burden.
Also requires a new diagnostic and therapeutic strategies.
COPD and heart failure in a cohort of metoezavisimoy disease or illness sodden feet wet wind and aggravated in damp wet seasons.
Note that beta-blockers with intrinsic sympathomimetic activity may be used in patients with COPD, and even demonstrated in these patients, so all is not gloomy in this problem is not simple as it might seem at first glance.
Case 6 CHF COPD.mp4
Matt Brancaleone, Alyssa Kelley, Jessica Wardynski, Evan Paulson
Table of Contents:
00:01 - Case #6CHF/COPD -- Mary Rosa
00:11 - Description of Case
01:51 - Main Problems Identified- ICF Model
04:44 - ICF Model Continued
05:38 - Goals: to be completed in 3 weeks
07:01 - Intervention
09:20 - Case Study
11:24 - Case Study Cont.
13:04 - Article Review-6-Minute Walk Work for Assessment of Functional Capacity in Patients With COPD1
15:42 - Article Review- Pedometer2
18:49 - Article Review- NVA237 Treatment3
20:24 - NVA237 Treatment Cont.3
22:12 - Article Review- Pursed Lip Breathing4
22:55 - Pursed Lip Breathing Cont.4
24:30 - Pursed Lip Breathing Cont.4
25:41 - Reasons for Results4:
26:16 - Implications for PT4
26:47 - Clinical Pearls1-4
27:03 - References
